Standard BioTools Quick Ratio 2010-2025 | LAB
Historical quick ratio values for Standard BioTools (LAB) over the last 10 years.
| Standard BioTools Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $0.30B | $0.06B | 5.37 |
| 2024-12-31 | $0.34B | $0.07B | 5.09 |
| 2024-09-30 | $0.41B | $0.12B | 3.41 |
| 2024-06-30 | $0.44B | $0.12B | 3.53 |
| 2024-03-31 | $0.51B | $0.12B | 4.17 |
| 2023-12-31 | $0.14B | $0.11B | 1.26 |
| 2023-09-30 | $0.15B | $0.05B | 2.87 |
| 2023-06-30 | $0.16B | $0.05B | 3.44 |
| 2023-03-31 | $0.17B | $0.04B | 3.94 |
| 2022-12-31 | $0.19B | $0.04B | 4.31 |
| 2022-09-30 | $0.21B | $0.05B | 4.49 |
| 2022-06-30 | $0.23B | $0.04B | 5.33 |
| 2022-03-31 | $0.05B | $0.05B | 1.06 |
| 2021-12-31 | $0.05B | $0.05B | 1.03 |
| 2021-09-30 | $0.05B | $0.05B | 1.04 |
| 2021-06-30 | $0.05B | $0.05B | 1.01 |
| 2021-03-31 | $0.07B | $0.05B | 1.39 |
| 2020-12-31 | $0.10B | $0.05B | 1.81 |
| 2020-09-30 | $0.10B | $0.04B | 2.41 |
| 2020-06-30 | $0.06B | $0.04B | 1.55 |
| 2020-03-31 | $0.07B | $0.04B | 1.87 |
| 2019-12-31 | $0.08B | $0.03B | 2.51 |
| 2019-09-30 | $0.08B | $0.03B | 2.44 |
| 2019-06-30 | $0.09B | $0.04B | 2.48 |
| 2019-03-31 | $0.10B | $0.03B | 2.86 |
| 2018-12-31 | $0.11B | $0.04B | 3.04 |
| 2018-09-30 | $0.06B | $0.04B | 1.45 |
| 2018-06-30 | $0.06B | $0.04B | 1.64 |
| 2018-03-31 | $0.07B | $0.03B | 1.95 |
| 2017-12-31 | $0.08B | $0.03B | 2.38 |
| 2017-09-30 | $0.08B | $0.03B | 2.46 |
| 2017-06-30 | $0.06B | $0.03B | 1.76 |
| 2017-03-31 | $0.07B | $0.03B | 2.12 |
| 2016-12-31 | $0.08B | $0.03B | 2.60 |
| 2016-09-30 | $0.09B | $0.03B | 3.13 |
| 2016-06-30 | $0.11B | $0.03B | 3.37 |
| 2016-03-31 | $0.12B | $0.03B | 3.87 |
| 2015-12-31 | $0.13B | $0.03B | 4.19 |
| 2015-09-30 | $0.13B | $0.03B | 4.60 |
| 2015-06-30 | $0.13B | $0.03B | 4.31 |
| 2015-03-31 | $0.14B | $0.03B | 5.54 |
| 2014-12-31 | $0.14B | $0.03B | 4.76 |
| 2014-09-30 | $0.12B | $0.03B | 4.24 |
| 2014-06-30 | $0.11B | $0.03B | 4.07 |
| 2014-03-31 | $0.17B | $0.03B | 6.43 |
| 2013-12-31 | $0.10B | $0.02B | 5.37 |
| 2013-09-30 | $0.08B | $0.02B | 5.23 |
| 2013-06-30 | $0.07B | $0.01B | 6.31 |
| 2013-03-31 | $0.09B | $0.01B | 7.90 |
| 2012-12-31 | $0.09B | $0.01B | 8.11 |
| 2012-09-30 | $0.10B | $0.01B | 7.49 |
| 2012-06-30 | $0.05B | $0.02B | 3.32 |
| 2012-03-31 | $0.05B | $0.02B | 2.83 |
| 2011-12-31 | $0.06B | $0.02B | 3.18 |
| 2011-09-30 | $0.07B | $0.02B | 3.57 |
| 2011-06-30 | $0.08B | $0.02B | 4.29 |
| 2011-03-31 | $0.09B | $0.02B | 4.65 |
| 2010-12-31 | $0.02B | $0.02B | 0.86 |
| 2010-09-30 | $0.01B | $0.01B | 1.11 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-03-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.475B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.177B | 57.48 |
| Doximity (DOCS) | United States | $11.570B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.189B | 116.26 |
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.774B | 58.97 |
| Hinge Health (HNGE) | United States | $3.628B | 0.00 |
| Privia Health (PRVA) | United States | $2.525B | 172.58 |
| Enovis (ENOV) | United States | $1.763B | 9.83 |
| Schrodinger (SDGR) | United States | $1.589B | 0.00 |
| Phreesia (PHR) | United States | $1.543B | 0.00 |
| 10x Genomics (TXG) | United States | $1.533B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.470B | 68.32 |
| Evolent Health (EVH) | United States | $1.323B | 112.70 |
| Omnicell (OMCL) | United States | $1.310B | 23.12 |
| Claritev (CTEV) | United States | $0.733B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.552B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.457B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.328B | 728.33 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.282B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| CapsoVision (CV) | United States | $0.218B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.107B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |